IBB | iShares Biotechnology ETFNASDAQETF golden cross and death cross projections, cross tests and history

$215.47
+$1.68 (+0.79%)

iShares Biotechnology ETF (IBB) is a NASDAQ-listed ETF that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $215.47 vs 50 $208.49 / 200 $185.19
Projection
No cross projected
Test
No active test
Last cross
Golden cross 25 Aug 2025 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $217.61 vs 50 $182.10 / 200 $145.91
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 4 Nov 2024 ยท projected 27 bars out ยท tested 5 bars

4-hour as of 3 Nov 16:00 ET

Price
above both $215.47 vs 50 $208.24 / 200 $199.79
Projection
No cross projected
Test
No active test
Last cross
Golden cross 24 Jun 2026 ยท projected 25 bars out

Cross history

32
crosses on record since 2018
16 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
24 Jun 2026Golden4-hour25 bars outNot tested
19 May 2026Death4-hour13 bars out1 bar cross test
5 May 2026Golden4-hour3 bars out7 bar cross test
26 Mar 2026Death4-hour25 bars out2 bar cross test
25 Aug 2025Golden steepdaily25 bars outNot tested

About IBB

ExchangeNASDAQ
InstrumentETF
Median $ volume, 60 d$326M
4-hour coverageYes, since Oct 2025
History on recordSince 2018

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.